David Burger (Oct. 20, 1964) received his Pharmacy Degree at the Utrecht University in 1990 and completed his PhD thesis in 1994. After this, he moved to the Radboud University Medical Centre, Nijmegen, for his hospital pharmacist training.
Since 1997 he has been leading a research group focussing on clinical pharmacology of antimicrobial agents with emphasis on HIV, TB, fungal infections, and Hepatitis. He is a member of the Editorial Board of the www.hiv-druginteractions.org and www.hep-druginteractions.org websites.
He is an Excecutive Editor of BJCP and serves on the editorial boards of TDM, JAIDS, JAC, Antiviral Therapy.
Since April 2011 he has been appointed as a Professor of Clinical Pharmacy at the Radboud University Nijmegen. He is (co-) author of more than 450 publications in this field and has supervised 27 completed PhD theses. The topics of his interest are drug-drug interactions, pediatric pharmacology, therapeutic drug monitoring, and operational research in resource-limited countries.
